Suchergebnisse - "Gadelha, Mônica"

PubPharm (12)

1

Innovative therapeutics in acromegaly

enthalten in: Best practice & research. Clinical endocrinology & metabolism | 2022

von Kasuki, L. | Gadelha, M.

2

MicroRNA in Acromegaly : Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands

enthalten in: International journal of molecular sciences | 2022

von Henriques, D. | Lamback, E. | Dezonne, R. | +2

3

GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly : a comparative study between two reference centers for pituitary diseases in Brazil

enthalten in: Endocrine | 2021

von Manosso, K. | Sampaio, C. | Kasuki, L. | +3

4

New and emerging pharmacological treatment options for acromegaly

enthalten in: Expert opinion on pharmacotherapy | 2021

von Antunes, X. | Kasuki, L. | Gadelha, M.

5

Pasireotide for acromegaly : long-term outcomes from an extension to the Phase III PAOLA study

enthalten in: European journal of endocrinology | 2020

von Colao, A. | Bronstein, M. | Brue, T. | +9

6

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

enthalten in: Endocrine | 2016

von Schmid, H. | Brue, T. | Colao, A. | +5

CommentIn: Endocrine. 2016 Oct;54(1):1-2. - PMID 27388591

7

Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly

enthalten in: Pituitary | 2016

von Colao, A. | Auriemma, R. | Pivonello, R. | +2

8

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control : crossover extension to a randomized, double-blind, Phase III study

enthalten in: BMC endocrine disorders | 2016

von Bronstein, M. | Fleseriu, M. | Neggers, S. | +11

9

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR : the LEAD study

enthalten in: European journal of endocrinology | 2015

von Neggers, S. | Pronin, V. | Balcere, I. | +46

10

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA) : a randomised, phase 3 trial

enthalten in: The lancet. Diabetes & endocrinology | 2014

von Gadelha, M. | Bronstein, M. | Brue, T. | +63

CommentIn: Lancet Diabetes Endocrinol. 2014 Nov;2(11):855-6. - PMID 25260837